CB 3705

CAT: 0804-HY-122045Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-122045Size:1 Each
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
CB 3705 is a dihydrofolate reductase (DHFR) and thymidylate synthetase (TS) inhibitor. CB 3705 inhibits L1210 cells and mutant L1210 cell line (L1210:C15) with ID50s of 4.77 μM and 408 μM, respectively[1][2].
CAS Number
[5854-11-5]
UNSPSC
12352005
Target
Dihydrofolate reductase (DHFR) ; Thymidylate Synthase
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C(O)CC[C@@H](C(O)=O)NC(C1=CC=C(NCC2=CC3=C(NC(N)=NC3=O)C=C2)C=C1)=O
Molecular Formula
C21H21N5O6
Molecular Weight
439.42
References & Citations
[1]Calvert AH, et al. Quinazoline antifolates with dual biochemical loci of action. Biochemical and biological studies directed towards overcoming methotrexate resistance. Eur J Cancer (1965) . 1980 May;16 (5) :713-22. |[2]Jackman AL, et al. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717) : development, characterization, and cross-resistance studies. Cancer Res. 1986 Jun;46 (6) :2810-5.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Popular Products